CHAMPIONS ONCOLOGY, INC. (CSBR) Net margin 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) net profit margin by fiscal year — reported net income divided by reported revenue.
-2.0%FY2026 · since FY2018: -7.3% → -2.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -2.0% | -10.2 pp |
| FY2025 | 8.3% | +22.8 pp |
| FY2024 | -14.5% | -4.6 pp |
| FY2023 | -9.9% | -11.0 pp |
| FY2022 | 1.1% | +0.2 pp |
| FY2021 | 0.9% | +7.4 pp |
| FY2020 | -6.5% | -7.0 pp |
| FY2019 | 0.5% | +7.8 pp |
| FY2018 | -7.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Gross profitCSBR Gross marginCSBR Operating incomeCSBR Operating marginCSBR Operating cash flowCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →